Alaska Permanent Fund’s Eli Lilly LLY Stock Holding History

Alaska Permanent Fund’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18,232	Closed	-$16.4M	–	253
2025 Q1	$16.4M	Hold	18,232	–	–	0.23%	40
2024 Q4	$14.1M	Hold	18,232	–	–	0.21%	46
2024 Q3	$16.2M	Hold	18,232	–	–	0.24%	42
2024 Q2	$14.7M	Buy	18,232 +138	+0.8%	+$110K	0.22%	46
2024 Q1	$14.1M	Sell	18,094 -85	-0.5%	-$60.5K	0.21%	44
2023 Q4	$10.6M	Sell	18,179 -5,764	-24%	-$3.36M	0.17%	65
2023 Q3	$12.9M	Sell	23,943 -4,731	-16%	-$2.44M	0.24%	45
2023 Q2	$13.4M	Buy	+28,674	New	+$12M	0.26%	42
2022 Q4	$3.67M	Sell	10,021 -1,646	-14%	-$584K	0.06%	102
2022 Q3	$3.77M	Sell	11,667 -277	-2%	-$87.8K	0.07%	90
2022 Q2	$3.87M	Buy	11,944 +11,067	+1,262%	+$3.32M	0.06%	84
2022 Q1	$251K	Sell	877 -277	-24%	-$71.3K	﹤0.01%	247
2021 Q4	$283K	Buy	+1,154	New	+$293K	0.01%	241

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alaska Permanent Fund's LLY Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 18,232 shares — an estimated $16.4M sold.

Alaska Permanent Fund first reported a position in LLY in Q4 2021 and held it in 13 quarters. The position peaked at $16.4M in Q1 2025. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

Alaska Permanent Fund reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
Alaska Permanent Fund sold 18,232 Eli Lilly shares in Q2 2025, an estimated $16.4M.
Alaska Permanent Fund first reported a position in Eli Lilly in Q4 2021 and held it in 13 quarters.
Alaska Permanent Fund's Eli Lilly position peaked at $16.4M in Q1 2025.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.